Human cervicovaginal mucus contains an activity that hinders HIV-1 movement

por Shukair, Shetha A., Allen, Shannon A., Cianci, Gianguido C., Stieh, Daniel J., Anderson, Meegan R., Baig, Samir M., Gioia, Casey J., Spongberg, Eric J., Kauffman, Sarah M., McRaven, Michael D., Lakougna, Howard Y., Hammond, Cassing, Kiser, Patrick F., Hope, Thomas J.
Publicado 2012

Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya

por Dabee, Smritee, Mugo, Nelly, Mudhune, Victor, McLellan-Lemal, Eleanor, Peacock, Sue, O’Connor, Siobhan, Njoroge, Betty, Nyagol, Beatrice, Thurman, Andrea R., Ouma, Eunice, Ridzon, Renee, Wiener, Jeffrey, Haugen, Harald S., Gasper, Melanie, Feng, Colin, Allen, Shannon A., Doncel, Gustavo F., Jaspan, Heather B., Heffron, Renee
Publicado 2022

Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract

por Carias, Ann M., Allen, Shannon A., Fought, Angela J., Kotnik Halavaty, Katarina, Anderson, Meegan R., Jimenez, Maria L., McRaven, Michael D., Gioia, Casey J., Henning, Tara R., Kersh, Ellen N., Smith, James M., Pereira, Lara E., Butler, Katherine, McNicholl, S. Janet M., Hendry, R. Michael, Kiser, Patrick F., Veazey, Ronald S., Hope, Thomas J.
Publicado 2016

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by...

por Mugo, Nelly R., Mudhune, Victor, Heffron, Renee, Thomas, Katherine K., McLellan-Lemal, Eleanor, Njoroge, Betty, Peacock, Sue, O’Connor, Siobhán M., Nyagol, Beatrice, Ouma, Eunice, Ridzon, Renee, Wiener, Jeffrey, Isoherranen, Nina, Erikson, David W., Ouattara, Louise A., Yousefieh, Nazita, Jacot, Terry A., Haaland, Richard E., Morrison, Susan A., Haugen, Harald S., Thurman, Andrea R., Allen, Shannon A., Baeten, Jared M., Samandari, Taraz, Doncel, Gustavo F.
Publicado 2023